Further characterization of ocular safety profile of commercially available preserved and preservative-free triamcinolone acetonide

Retina

Volumn 32, Issue 2, 2012, Pages 364-374

  Li, Yuli ^a   Chen, Hao ^a   Hou, Jiangping ^a   Zhang, Yin ^a   Li, Guoxing ^a   Gu, Xin ^a   Luo, Li ^a   Shen, Huanjun ^a   Qu, Jia ^a   Cheng, Lingyun ^a,b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

guinea pig eye; intravitreal injection; ocular safety and toxicity; retinal cell culture; retinal cell cytotoxicity; triamcinolone acetonide

Indexed keywords

EXCIPIENT; PRESERVATIVE; TRIAMCINOLONE ACETONIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMICROSCOPY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG SAFETY; ELECTRORETINOGRAPHY; EXPERIMENTAL GUINEA PIG; EYE TOXICITY; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MUELLER CELL; NONHUMAN; OPHTHALMOSCOPY; PIGMENT EPITHELIUM; TONOMETRY;

ANIMALS; APOPTOSIS; BENZYL ALCOHOL; CELL SURVIVAL; CELLS, CULTURED; DRUG COMBINATIONS; ELECTRORETINOGRAPHY; GLUCOCORTICOIDS; GUINEA PIGS; HUMANS; INTRAVITREAL INJECTIONS; MANOMETRY; NEUROGLIA; OPHTHALMOSCOPY; PRESERVATIVES, PHARMACEUTICAL; RETINA; RETINAL PIGMENT EPITHELIUM; TRIAMCINOLONE ACETONIDE;

EID: 84856601799     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31821e1f7c     Document Type: Article

References (39)

1. Chung EJ, Freeman WR, Azen SP, et al. Comparison of combination posterior sub-Tenon triamcinolone and modified grid laser treatment with intravitreal triamcinolone treatment in patients with diffuse diabetic macular edema. Yonsei Med J 2008;49:955-964.
2. Gewaily D, Greenberg PB. Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion. Cochrane Database Syst Rev 2009;1: CD007324.
3. Patel PJ, Zaheer I, Karia N. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion. Eye 2008;22:60-64.
4. Roth DB, Cukras C, Radhakrishnan R, et al. Intravitreal triamcinolone acetonide injections in the treatment of retinal vein occlusions. Ophthalmic Surg Lasers Imaging 2008;39: 446-454.
5. Roth DB, Verma V, Realini T, et al.Long-term incidence and timing of intraocular hypertension after intravitreal triamcin-olone acetonide injection. Ophthalmology 2009;116:455-460.
6. Jermak CM, Dellacroce JT, Heffez J, Peyman GA. Triamcinolone acetonide in ocular therapeutics. Surv Oph-thalmol 2007;52:503-522. (Pubitemid 47268546)
7. Sakamoto T, Hida T, Tano Y, et al. Survey of triamcinolone acetonide for ocular diseases in Japan [in Japanese]. Nippon Ganka Gakkai Zasshi 2007;111:936-945.
8. Kim H, Csaky KG, Gravlin L, et al. Safety and pharmaco-kinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administration. Retina 2006;26:523-530. (Pubitemid 44620393)
9. Garcia-Arumi J, Boixadera A, Giralt J, et al. Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use. Br J Ophthalmol 2005;89: 1112-1114. (Pubitemid 41224456)
10. Chang YS, Wu CL, Tseng SH, et al. Cytotoxicity of triamcinolone acetonide on human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2007;48:2792-2798.
11. Narayanan R, Mungcal JK, Kenney MC, et al. Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci 2006;47: 722-728. (Pubitemid 46768403)
12. Shaikh S, Ho S, Engelmann LA, Klemann SW. Cell viability effects of triamcinolone acetonide and preservative vehicle formulations. Br J Ophthalmol 2006;90:233-236. (Pubitemid 43163858)
13. Albini TA, Abd-El-Barr MM, Carvounis PE, et al. Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes. Invest Ophthalmol Vis Sci 2007;48:390-395. (Pubitemid 47251429)
14. Li Q, Wang J, Yang L, et al. A morphologic study of retinal toxicity induced by triamcinolone acetonide vehicles in rabbit eyes. Retina 2008;28:504-510. (Pubitemid 351354955)
15. Yu SY, Damico FM, Viola F, et al. Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study. Retina 2006;26:531-536. (Pubitemid 44620394)
16. Franze K, Grosche J, Skatchkov SN, et al. Müller cells are living optical fibers in the vertebrate retina. Proc Natl Acad Sci U S A 2007;104:8287-8292. (Pubitemid 47175480)
17. Quiram PA, Leverenz VR, Baker RM, et al. Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels. Retina 2007;27:1090-1096. (Pubitemid 350304013)
18. Racine J, Behn D, Lachapelle P. Structural and functional maturation of the retina of the albino Hartley guinea pig. Doc Ophthalmol 2008;117:13-26.
19. Cavallotti C, Artico M, Pescosolido N, et al. Distribution of peptidergic nerve fibres in the guinea pig trabecular meshwork. Anat Histol Embryol 2000;29:387-391. (Pubitemid 32093381)
20. Sasamoto M, Chen HB, Tsukahara S. Ultrastructural identification of substance P containing nerves in the guinea pig trabecular meshwork. Ophthalmic Res 1998;30:127-134. (Pubitemid 28242943)
21. Lu S, Cheng L, Hostetler KY, et al. Intraocular properties of hexadecyloxypropyl-cyclic-cidofovir in Guinea pigs. J Ocul Pharmacol Ther 2005;21:205-209. (Pubitemid 40934698)
22. Swann DA, Constable IJ. Vitreous structure. II. Role of hyaluronate. Invest Ophthalmol 1972;11:164-168.
23. Hui M, Kwok AK, Pang CP, et al. An in vitro study on the compatibility and precipitation of a combination of cipro-floxacin and vancomycin in human vitreous. Br J Ophthalmol 2004;88:218-222. (Pubitemid 38142090)
24. Peyman GA, Lee PJ, Seal DV. Endophthalmitis: Diagnosis and Treatment London: Taylor & Francis; 2004:97.
25. Limb GA, Salt TE, Munro PM, et al. In vitro characterization of a spontaneously immortalized human Müller cell line (MIO-M1). Invest Ophthalmol Vis Sci 2002;43: 864-869. (Pubitemid 34184508)
26. Lawrence JM, Singhal S, Bhatia B, et al. MIO-M1 cells and similar Müller glial cell lines derived from adult human retina exhibit neural stem cell characteristics. Stem Cells 2007;25: 2033-2043. (Pubitemid 47258181)
27. Cheng L, Hostetler KY, Lee J, et al. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir. Invest Ophthalmol Vis Sci 2004;45:4138-4144. (Pubitemid 39411172)
28. Morrison VL, Koh HJ, Cheng L, et al. Intravitreal toxicity of the Kenalog vehicle (benzyl alcohol) in rabbits. Retina 2006; 26:339-344. (Pubitemid 44318189)
29. Kai W, Yanrong J, Xiaoxin L. Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density. Graefes Arch Clin Exp Ophthalmol 2006;244:1152-1159. (Pubitemid 44269594)
30. Ruiz-Moreno JM, Montero JA, Bayon A, et al. Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit. Exp Eye Res 2007;84:342-348. (Pubitemid 46016935)
31. Taygan Y, Christopher DW, Micheal JG, et al. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review. Ophthalmology 2009;116:902-913.
32. Krzystolik MG, Afshari MA, Adamis AP, et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 2002;120:338-346. (Pubitemid 34250056)
33. Cheng L, Hostetler KY, Gardner MF, et al. Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug. Invest Ophthalmol Vis Sci 1999;40: 1487-1495. (Pubitemid 29252340)
34. Cheng L, Hostetler KY, Chaidhawangul S, et al. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation. Invest Ophthalmol Visual Sci 2000;41:1523-1532. (Pubitemid 30261879)
35. Bitter C, Suter K, Figueiredo V, et al. Preservative-free triamcinolone acetonide suspension developed for intravitreal injection. J Ocul Pharmacol Ther 2008;24:62-69. (Pubitemid 351156630)
36. Dierks D, Lei B, Zhang K, Hainsworth DP. Electroretino-graphic effects of an intravitreal injection of triamcinolone in rabbit retina. Arch Ophthalmol 2005;123:1563-1569. (Pubitemid 41626693)
37. Maia M, Penha FM, Farah ME, et al. Subretinal injection of preservative-free triamcinolone acetonide and supernatant vehicle in rabbits: an electron microscopy study. Graefes Arch Clin Exp Ophthalmol 2008;246:379-388.
38. 14C- triamcinolone acetonide. J Pharm Sci 1976;65:429-430.
39. Bates RG, Vega CA, White DRJ. Standards for pH measurements in isotonic saline media of ionic strength I = 0.16. Anal Chem 1978;50:1295.